At review three weeks later a supraventricular tachycardia was noted. This reverted spontaneously to sinus rhythmn on admission to hospital. He was discharged with a prescription for Digoxin 0-25 mg daily. Two weeks later he was admitted as an emergency with severe dyspnoea. Examination showed signs consistent with cardiac tamponade.
(CMML) is a myelodysplastic syndrome with a diverse clinical spectrum. A case of a 60 year old man with CMML who developed cardiac tamponade is reported. Cytological emination of the pericardial effusion fluid showed extramedullary haemopoeisis. Serous effusions are well recognised in association with this disease, but this seems to be the first reported case of extramedullary haemopoiesis resulting in a pericardial effusion in a patient with CMML. ( At review three weeks later a supraventricular tachycardia was noted. This reverted spontaneously to sinus rhythmn on admission to hospital. He was discharged with a prescription for Digoxin 0-25 mg daily. Two weeks later he was admitted as an emergency with severe dyspnoea. Examination showed signs consistent with cardiac tamponade.
A full blood count showed that his leukaemia had progressed (haemoglobin 100 g/l, a white cell count of 50 2 x 109/1 (neutrophils 74%, lymphocytes 2%, monocytes 20%, basophils 1%, myelocytes 3%), and a platelet count of 217 x 109/1. An echocardiogram showed a pericardial effusion with severely compromised cardiac function, pericardial thickening, and epicardial irregularities (fig 1) . The effusion was drained under ultrasound control of 1 2 litres of fluid with immediate symptomatic relief. The pericardial fluid had a haemoglobin concentration of Pericardial
A stained (Wright's) cytospin preparation of the pericardial fluid showed a small number of nucleated red cells, occasional megakaryocytes, and numerous myelocytes and monocytes suggesting extramedullary haemopoiesis in the pericardial space (fig 2) . Chemotherapy was started with etoposide 100 mg/M2 intravenously, days 1-3, cytosine arabinoside 150 mg twice daily intravenously for five days, and prednisolone 40 mg daily by mouth.
Treatment was well tolerated with a good clinical and haematological response. Repeat echocardiographs showed no recurrence of the pericardial effusion. Continuous oral etoposide was prescribed for the next three months.
Five months after the initial presentation he was readmitted to hospital with tense ascites. Pronunced hepatosplenomegaly with abdominal lymphadenopathy was evident on a computed tomogram. A cytospin of the ascitic fluid showed 0 1 x 1 09 cells/l, all of which were mature monocytes. Five days of intravenous cytosine arabinoside was given (100 mg/M2 twice a day) with a good initial response. The ascites returned within four weeks. Paracentesis, intraperitoneal bleomycin, and chemotherapy with hydroxyurea all failed to give other than short term control. A third course of cytosine arabinoside and etoposide were given without response and his condition deteriorated. He died 10 months after presentation.
Discussion
Ascites and effusions affecting the pleural and pericardial spaces have previously been described in patients in CMML.346 These have all been serous effusions usually containing monocytes.
The unusual features of the pericardial effusion in this case were the cytological characteristics of the pericardial fluid, suggesting extramedullary haemopoeisis.
A computed tomogram performed after pericardiocentesis showed enlarged superior mediastinal lymph nodes with pericardial thickening. Lymphadenopathy is well recognised in CMML,'4 and may be due to infiltration by monocytes6 or a concomitant lymphoproliferative disorder.7 More recently, extramedullary haemopoiesis has been described as a cause of mediastinal lymphadenopathy in CMML.8
The echocardiogram in this case showed evidence of pericardial and epicardial infiltration, and when taken with the cytospin findings, suggests that both the pericardium and epicardium were sites of extramedullary haemopoiesis leading to the development of the effusion.
CMML is a heterogenous disorder. Studies examining prognostic factors in CMML have identified the importance of a high peripheral blood monocyte count at presentation3 and an increase in blood or bone marrow blast cells.'9 The modified Boumemouth score would not have identified this patient as belonging to a poor prognosis group at presentation, but the monocyte count at presentation was 4-6 x 109/1, and a concentration of >2-6 x 109/1 may identify a poor prognosis group of patients with a median survival of just 11 months. 10 Both the pericardial effusion and serous ascites occurred when the monocyte count was rapidly rising. Contrary to the experience reported by Mufti et al,4 the ascites was particularly resistant to treatment.
We believe this to be the first description of cardiac tamponade in CMML associated with extramedullary haemopoiesis affecting the pericardium. Effusions in CMML occur more frequently in patients with high or rising monocyte counts, and may identify a subgroup of patients with a poor prognosis. 
